Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 1, 2009, Pages 14-18

  Liyan, Cui ^a   Jie, Zhang ^a   Xiaozhou, Hu ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Biomarkers; Fatty acid binding proteins; Myocardial ischemia

Indexed keywords

FATTY ACID BINDING PROTEIN; ISCHEMIA MODIFIED ALBUMIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; THORAX PAIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; BIOLOGICAL MARKERS; CHEST PAIN; CHINA; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; TROPONIN T;

EID: 58849143535     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20276     Document Type: Article

References (27)

1. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
2. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002;23:1809-1840.
3. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
4. Hamm CW. Acute coronary syndromes: The diagnostic role of troponins. Tromb Res 2001;103:S63-S69.
5. Chan CP, Wan TS, Watkins KL, et al. Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury. Biosens Bioelectron 2005; 20:2566-2580.
6. Alhadi HA, Fox KA. Do we need additional markers of myocyte necrosis: The potential value of heart fatty-acid-binding protein. Q J Med 2004;97:187-198.
7. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005;352:15-35.
8. Pagani F, Bonora R, Bonetti G. Evaluation of a sandwich enzyme-linked immunosorbent assay for the measurement of serum heart fatty acid-binding protein. Ann Clin Biochem 2002;39:404-405.
9. Glatz JF, van der Vusse GJ. Cellular fatty acid-binding proteins: Their function and physiological significance. Prog Lipid Res 1996;35:243-282.
10. Storch J, Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 2000;1486:28-44.
11. Schaap FG, Binas B, Danneberg H, van der Vusse GJ, Glatz JF. Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 1999;85:329-337.
12. Fournier NC, Richard MA. Role of fatty acid-binding protein in cardiac fatty acid oxidation. Mol Cell Biochem 1990;98:149-159.
13. Pelsers MM, et al. Influence of age, sex and day-to-day and within-day biological variations on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 1999;45:441-443.
14. Bruins Slot MH, van der Heijden GJ, Rutten FH, et al. Heart-type fatty acid-binding protein in acute myocardial infarction evaluation (FAME): background and design of a diagnostic study in primary care. BMC Cardiovasc Disord 2008;8:8.
15. Figiel L, Kasprzak JD, Peruga J, et al. Heart-type fatty acid binding protein-a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation. Kardiol Pol 2008;66:253-259.
16. Mad P, Domanovits H, Fazelnia C, et al. Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM 2007;100:203-210.
17. O'Donoghue M, de Lemos JA, Morrow DA, et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006;114:550-557.
18. Nahahara D, Nakata T, Hashimoto A, et al. Early positive biomarker in relation to myocardial necrosis and impaired fatty acid metabolism in patients presenting with acute chest pain at an emergency room. Circ J 2006;70:419-425.
19. Suzuki M, Hori S, Noma S, et al. Prognostic value of a qualitative test for heart-type fatty acid-binding protein in patients with acute coronary syndrome. Int Heart J 2005;46:601-606.
20. Liyan C, Jie Z, Yonghua W, et al. Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes. J Clin Lab Anal 2008;22:45-49.
21. Erlikh A, Katrukha AG, Trifonov IR, et al. Prognostic significance of heart fatty acid-binding protein in patients with non-ST elevation acute coronary syndrome: results of follow-up for twelve months. Kardiologiia 2005;45:13-21.
22. Christenson RL, Duh SH, Sanhai WR, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-470.
23. Sinha MK, Roy D, Gaze DC, et al. Role of ''Ischemia modified albumin'', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
24. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
25. Tanaka T, Hirota Y, Sohmiya K, et al. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991;24:195-201.
26. Kleine AH, Glatz JF, Van Nieuwenhoven FA, et al. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992;116:155-162.
27. Nakata T, Hashimoto A, Hase M, et al. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 2003;99:96-104.